Manuel Rosa-Calatrava
Overview
Explore the profile of Manuel Rosa-Calatrava including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
1660
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Padey B, Droillard C, Duliere V, Fouret J, Lamballerie C, Milesi C, et al.
Antiviral Res
. 2025 Mar;
:106138.
PMID: 40049293
Viral respiratory infections remain a major and recurrent public health threat. Among them, influenza viruses are responsible for ⁓500,000 deaths worldwide and a high economic burden. The recurrent threat of...
2.
Yaugel-Novoa M, Noailly B, Jospin F, Pizzorno A, Traversier A, Pozzetto B, et al.
Emerg Microbes Infect
. 2024 Oct;
13(1):2401940.
PMID: 39358866
Several studies have investigated the antibody response to SARS-CoV-2, focusing particularly on the systemic humoral immune response and the production of immunoglobulin G (IgG) antibodies. IgA antibodies play a crucial...
3.
Ogonczyk-Makowska D, Brun P, Vacher C, Chupin C, Droillard C, Carbonneau J, et al.
NPJ Vaccines
. 2024 Jul;
9(1):125.
PMID: 38982077
No abstract available.
4.
Gonzalez Gomez C, Rosa-Calatrava M, Fouret J
Brief Bioinform
. 2024 Jun;
25(4).
PMID: 38935068
Background: We present a novel simulation method for generating connected differential expression signatures. Traditional methods have struggled with the lack of reliable benchmarking data and biases in drug-disease pair labeling,...
5.
Ogonczyk-Makowska D, Brun P, Vacher C, Chupin C, Droillard C, Carbonneau J, et al.
NPJ Vaccines
. 2024 Jun;
9(1):111.
PMID: 38898106
Live-Attenuated Vaccines (LAVs) stimulate robust mucosal and cellular responses and have the potential to protect against Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (HMPV), the main etiologic agents of viral...
6.
Prenafeta A, Bech-Sabat G, Moros A, Barreiro A, Fernandez A, Canete M, et al.
iScience
. 2023 Jul;
26(7):107224.
PMID: 37502366
SARS-CoV-2 emerged in December 2019 and quickly spread worldwide, continuously striking with an unpredictable evolution. Despite the success in vaccine production and mass vaccination programs, the situation is not still...
7.
Szpiro L, Bourgeay C, Hoareau A, Julien T, Menard C, Marie Y, et al.
Materials (Basel)
. 2023 Apr;
16(7).
PMID: 37049183
Environmental surfaces, including high-touch surfaces (HITS), bear a high risk of becoming fomites and can participate in viral dissemination through contact and transmission to other persons, due to the capacity...
8.
Barateau V, Peyrot L, Saade C, Pozzetto B, Brengel-Pesce K, Elsensohn M, et al.
Sci Transl Med
. 2023 Mar;
15(687):eade0550.
PMID: 36921035
The diversity of vaccination modalities and infection history are both variables that have an impact on the immune memory of individuals vaccinated against SARS-CoV-2. To gain more accurate knowledge of...
9.
Feuillet F, Rosa-Calatrava M, Boivin G
Virologie (Montrouge)
. 2022 Sep;
15(4):235-250.
PMID: 36151673
Human metapneumovirus (hMPV), described for the first time in 2001 by the team of Pr Albert Osterhaus [1], is one of the main viral pathogens responsible for human respiratory tract...
10.
Josset L, Lina B, Rosa-Calatrava M
Virologie (Montrouge)
. 2022 Sep;
15(1):36-52.
PMID: 36151649
InfluenzaAviruses express up to 12 proteins and consequently depend on the host cellular machinery for their replication. During the last years, high throughput methods for screening and analysis allowed to...